# AbbVie's Biotech Investments: 31 Startups in Its Portfolio (2026) > The 31 Biotech startups AbbVie has backed, by stage: $2.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/abbvie-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 14 - [Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic) - [Caribou Biosciences](https://millionrounds.com/company/caribou-biosciences) - [Faze Medicines](https://millionrounds.com/company/faze-medicines) - [Light Horse Therapeutics](https://millionrounds.com/company/light-horse-therapeutics) - [Carisma](https://millionrounds.com/company/carisma) - [*J* Jnana](https://millionrounds.com/company/jnana) - [Quentis Therapeutics](https://millionrounds.com/company/quentis-therapeutics) - [*P* Palleon](https://millionrounds.com/company/palleon) - [Ribometrix](https://millionrounds.com/company/ribometrix) - [*MN* Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience) - [Stemson Therapeutics](https://millionrounds.com/company/stemson-therapeutics) - [Nitrase Therapeutics](https://millionrounds.com/company/nitrase-therapeutics) - [ApoGen Biotechnologies](https://millionrounds.com/company/apogen-biotechnologies) - [*A* ApoGen](https://millionrounds.com/company/apogen) ## Series C and later 7 - [Alector](https://millionrounds.com/company/alector) - [AM Pharma](https://millionrounds.com/company/am-pharma) - [Quanta Therapeutics](https://millionrounds.com/company/quanta-therapeutics) - [Jnana Therapeutics](https://millionrounds.com/company/jnana-therapeutics) - [Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics) - [Carisma Therapeutics](https://millionrounds.com/company/carisma-therapeutics) - [PACT Pharma](https://millionrounds.com/company/pact-pharma) ## Stage not reported 7 - [Syndeio Biosciences](https://millionrounds.com/company/syndeio-biosciences) - [Ribon Therapeutics](https://millionrounds.com/company/ribon-therapeutics) - [Magnolia NeuroSciences](https://millionrounds.com/company/magnolia-neurosciences) - [*RT* Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics) - [*A* Aquinnah](https://millionrounds.com/company/aquinnah) - [AmbAgon Therapeutics](https://millionrounds.com/company/ambagon-therapeutics) - [ThirtyFiveBio](https://millionrounds.com/company/thirtyfivebio) ## Series B 3 - [Palleon Pharmaceuticals](https://millionrounds.com/company/palleon-pharmaceuticals) - [Artios](https://millionrounds.com/company/artios) - [*PT* Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics) ## Segment by segment ### Series A 14 startups · $919M raised - [**Morphic Therapeutic**](https://millionrounds.com/company/morphic-therapeutic) Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases. United States $328M - [**Caribou Biosciences**](https://millionrounds.com/company/caribou-biosciences) Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology. United States $139M - [**Faze Medicines**](https://millionrounds.com/company/faze-medicines) Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $81M - [**Light Horse Therapeutics**](https://millionrounds.com/company/light-horse-therapeutics) Light Horse Therapeutics, Inc. United States $62M - [**Carisma**](https://millionrounds.com/company/carisma) Carisma is a provider of outsourced managed IT services. United States $53M - [*J* **Jnana**](https://millionrounds.com/company/jnana) United States $50M - [**Quentis Therapeutics**](https://millionrounds.com/company/quentis-therapeutics) Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. United States $49M - [*P* **Palleon**](https://millionrounds.com/company/palleon) United States $48M ### Series C and later 7 startups · $902M raised - [**Alector**](https://millionrounds.com/company/alector) Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases. United States $215M - [**AM Pharma**](https://millionrounds.com/company/am-pharma) AM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands. Netherlands $189M - [**Quanta Therapeutics**](https://millionrounds.com/company/quanta-therapeutics) Quanta Therapeutics, Inc. United States $127M - [**Jnana Therapeutics**](https://millionrounds.com/company/jnana-therapeutics) Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform. United States $107M - [**Effector Therapeutics**](https://millionrounds.com/company/effector-therapeutics) Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics. United States $99M - [**Carisma Therapeutics**](https://millionrounds.com/company/carisma-therapeutics) Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors. United States $90M - [**PACT Pharma**](https://millionrounds.com/company/pact-pharma) PACT Pharma is a clinical-stage biopharmaceutical company based in South San Francisco, California, founded in 2016. United States $75M ### Stage not reported 7 startups · $229M raised - [**Syndeio Biosciences**](https://millionrounds.com/company/syndeio-biosciences) Syndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to r United States $90M - [**Ribon Therapeutics**](https://millionrounds.com/company/ribon-therapeutics) Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways. United States $90M - [**Magnolia NeuroSciences**](https://millionrounds.com/company/magnolia-neurosciences) Magnolia Neurosciences is a private drug discovery and development company dedicated to creating innovative neuroprotective medici United States $18M - [*RT* **Rodeo Therapeutics**](https://millionrounds.com/company/rodeo-therapeutics) Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types. United States $15M - [*A* **Aquinnah**](https://millionrounds.com/company/aquinnah) United States $10M - [**AmbAgon Therapeutics**](https://millionrounds.com/company/ambagon-therapeutics) Ambagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, partic United States $5.0M - [**ThirtyFiveBio**](https://millionrounds.com/company/thirtyfivebio) ThirtyFiveBio is a UK-based biotechnology company founded in 2021, focused on developing first-in-class small-molecule inhibitors United Kingdom $306K ### Series B 3 startups · $233M raised - [**Palleon Pharmaceuticals**](https://millionrounds.com/company/palleon-pharmaceuticals) Palleon Pharmaceuticals is a clinical-stage biotechnology company based in Waltham, Massachusetts. United States $100M - [**Artios**](https://millionrounds.com/company/artios) Artios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus. United Kingdom $83M - [*PT* **Prevail Therapeutics**](https://millionrounds.com/company/prevail-therapeutics) United States $50M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names AbbVie as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with AbbVie** 30 co-investors](https://millionrounds.com/portfolio-maps/abbvie-co-investors)[Sector portfolio **Coinbase Ventures' Web3 & Crypto portfolio** 168 startups · $5.7B](https://millionrounds.com/portfolio-maps/coinbase-web3-crypto-portfolio)[Sector portfolio **Salesforce Ventures' AI portfolio** 115 startups · $181B](https://millionrounds.com/portfolio-maps/salesforce-ventures-ai-portfolio)[Sector portfolio **Google Ventures' AI portfolio** 81 startups · $16B](https://millionrounds.com/portfolio-maps/gv-ai-portfolio)[Sector portfolio **Google Ventures' Biotech portfolio** 74 startups · $12B](https://millionrounds.com/portfolio-maps/gv-biotech-portfolio)[Sector portfolio **Samsung Next's AI portfolio** 72 startups · $9.8B](https://millionrounds.com/portfolio-maps/samsung-next-ai-portfolio) ## Raising from investors like AbbVie? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)